BMSSC
RMD icon

B. Metzler seel. Sohn & Co’s ResMed RMD Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
9,095
-1,164
-11% -$241K 0.02% 447
2026
Q1 		$2.3M Hold
10,259
– – 0.02% 360
2025
Q4 		$2.47M Buy
10,259
+1,501
+17% +$384K 0.02% 354
2025
Q3 		$2.4M Hold
8,758
– – 0.02% 352
2025
Q2 		$2.26M Hold
8,758
– – 0.02% 355
2025
Q1 		$1.96M Buy
8,758
+1,928
+28% +$450K 0.02% 357
2024
Q4 		$1.56M Sell
6,830
-195
-3% -$47K 0.02% 435
2024
Q3 		$1.71M Hold
7,025
– – 0.02% 426
2024
Q2 		$1.34M Buy
7,025
+140
+2% +$28.4K 0.01% 464
2024
Q1 		$1.36M Buy
6,885
+990
+17% +$181K 0.02% 454
2023
Q4 		$1.01M Buy
5,895
+413
+8% +$63.5K 0.01% 507
2023
Q3 		$811K Sell
5,482
-69,535
-93% -$12.6M 0.01% 504
2023
Q2 		$16.4M Buy
75,017
+2,217
+3% +$494K 0.22% 63
2023
Q1 		$15.9M Buy
72,800
+6,377
+10% +$1.38M 0.25% 63
2022
Q4 		$13.8M Buy
66,423
+58,219
+710% +$12.8M 0.24% 73
2022
Q3 		$1.79M Hold
8,204
– – 0.03% 309
2022
Q2 		$1.72M Hold
8,204
– – 0.03% 331
2022
Q1 		$1.99M Sell
8,204
-1,835
-18% -$444K 0.03% 339
2021
Q4 		$2.63M Buy
10,039
+1,316
+15% +$341K 0.03% 281
2021
Q3 		$2.3M Sell
8,723
-377
-4% -$103K 0.03% 286
2021
Q2 		$2.24M Sell
9,100
-778
-8% -$164K 0.03% 280
2021
Q1 		$1.92M Buy
9,878
+2,269
+30% +$455K 0.03% 299
2020
Q4 		$1.67M Buy
+7,609
New +$1.52M 0.03% 307

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

B. Metzler seel. Sohn & Co's RMD Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $241K and leaving 9,095 shares worth $1.77M. The position accounts for 0.02% of the portfolio, ranked #447.

B. Metzler seel. Sohn & Co first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $16.4M in Q2 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 9,095 shares of ResMed worth $1.77M as of Q2 2026.
  • B. Metzler seel. Sohn & Co sold 1,164 ResMed shares in Q2 2026, an estimated $241K.
  • ResMed made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #447 holding.
  • B. Metzler seel. Sohn & Co first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's ResMed position peaked at $16.4M in Q2 2023.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.